Artificial and natural non-nutritive sweeteners drive divergent gut and genetic responses across generations19. April 2026
Health Abbott Integrates Precision Oncology Portfolio into Flatiron Health’s OncoEMR to Streamline Cancer CareHealthradar31. März 2026 What You Should Know: Integration: Abbott has partnered with Flatiron Health to natively integrate its Precision Oncology testing portfolio directly…
Health Adaptive Biotechnologies and Flatiron Health Integrate clonoSEQ MRD Test into OncoEMR®Healthradar2. Juli 2025 What You Should Know: – Adaptive Biotechnologies Corporation and Flatiron Health today announced the integration of Adaptive’s clonoSEQ® test for…
